Why Your Melatonin Stopped Working — And What to Do Instead
You started with one gummy. Then two. Then you switched to the 10mg tablets. Now you're taking melatonin every night and still lying awake, wondering if you got a bad batch.
You didn't. The melatonin is the same. Your expectations about what it does — that's the problem.
I have this conversation at least three times a week in my clinic. A patient walks in frustrated, sometimes angry, because the supplement that "everyone says works" has stopped working for them. And the answer is almost always the same: melatonin was never designed to treat insomnia.
The Melatonin Misconception
Melatonin is a hormone. Your pineal gland produces it naturally when light levels drop, signaling to your body that it's time to prepare for sleep. It's a timing signal, not a sedative.
This distinction matters enormously. When you take supplemental melatonin, you're not knocking yourself out. You're telling your circadian clock: "It's nighttime now." For someone with a circadian rhythm disorder — like delayed sleep phase or jet lag — this is exactly the right tool.
For someone with chronic insomnia? It's like adjusting the clock on your wall and expecting the traffic jam outside to clear.
The clinical evidence reflects this. A 2022 Cochrane meta-analysis — the gold standard of evidence reviews — examined 23 randomized controlled trials and found that melatonin reduced sleep onset latency by an average of 7 minutes and increased total sleep time by 8 minutes compared to placebo (Low et al., 2022).
Seven minutes faster to fall asleep. Eight minutes more sleep total. That's the actual effect size. The reason you feel like it "worked" the first few times is almost certainly placebo response, which in insomnia studies is typically 30-40%.
Why It Stops "Working"
Three mechanisms explain why melatonin loses its perceived effect:
1. Placebo decay. The most powerful sleep intervention in clinical trials is the belief that something will help. This fades naturally over 2-4 weeks as novelty wears off.
2. Receptor desensitization. While melatonin doesn't build tolerance in the same way as benzodiazepines, sustained supraphysiological doses (anything over 0.5mg — most commercial products are 5-10mg, which is 10-20x what your body produces) can downregulate melatonin receptors MT1 and MT2. Your brain literally becomes less sensitive to the signal.
3. Dose escalation without benefit. Most people respond to melatonin dose increases by... falling asleep at the same time. A 2021 study in Sleep found no significant difference in sleep onset between 0.5mg, 3mg, and 10mg doses in adults with insomnia. The 10mg group, however, reported significantly more morning grogginess and vivid dreams (Vural et al., 2021).
The Unregulated Reality
Here's something that should concern you: because melatonin is classified as a dietary supplement in the US (not a drug), it's not regulated by the FDA for quality or dosage accuracy.
A landmark 2023 JAMA study tested 25 commercial melatonin products and found that actual melatonin content ranged from -83% to +478% of the labeled dose. One in four products contained serotonin — a prescription substance — as a contaminant (Cohen et al., 2023).
You might be taking 2mg when the label says 10mg. Or 47mg when it says 10mg. There's no way to know without lab testing.
For context: in the European Union, Australia, and the UK, melatonin is prescription-only, available in a standardized 2mg controlled-release formulation (Circadin). The US approach of selling unregulated 10mg gummies next to the vitamins is, from a clinical perspective, reckless.
What Chronic Insomnia Actually Needs
If your insomnia has lasted more than three months, melatonin was never the right tool. Chronic insomnia is maintained by conditioned arousal — your brain has learned to associate the bed with wakefulness, anxiety, and frustration. No hormone supplement can unlearn that association.
Cognitive Behavioral Therapy for Insomnia (CBT-I) can. It's the only treatment with strong evidence for long-term insomnia resolution. The AASM, the ACP, and the European Sleep Research Society all recommend it as first-line therapy.
The core techniques:
- Stimulus control: rebuilding the bed = sleep association by following strict rules about when you're in bed and what you do there
- Sleep restriction: temporarily limiting time in bed to match actual sleep time, which builds sleep pressure and consolidates fragmented sleep
- Cognitive restructuring: identifying and reframing the catastrophic thoughts ("If I don't sleep tonight, tomorrow will be ruined") that fuel the arousal cycle
A 2024 meta-analysis in JAMA Psychiatry found these techniques produce a large effect size (g = 0.98) — roughly ten times the effect of melatonin — and the benefits persist at 12-month follow-up without any ongoing intervention (Furukawa et al., 2024).
Digital CBT-I programs like Zomni make this protocol accessible without a 6-month waitlist for a sleep clinic. The structured, AI-guided approach means you get the same evidence-based techniques adapted to your individual sleep data.
The Bottom Line
Melatonin is not a sleeping pill. It's a circadian signal that has been marketed as a cure-all for sleep problems. If it ever seemed to work for your chronic insomnia, the effect was likely placebo — and it has faded because that's what placebo effects do.
Stop chasing higher doses. Start addressing the behavioral patterns that are actually keeping you awake. That's not a supplement — it's a skill. And unlike melatonin, it doesn't stop working after two weeks.
References
- Low, T. L., et al. (2022). Melatonin for sleep disorders: a Cochrane systematic review. Cochrane Database of Systematic Reviews, 5, CD012776.
- Vural, E. M., et al. (2021). Dose-response relationship of melatonin in adults with insomnia. Sleep, 44(9), zsab134.
- Cohen, P. A., et al. (2023). Melatonin content and contaminants in US dietary supplements. JAMA, 329(16), 1401-1404.
- Furukawa, T. A., et al. (2024). Component network meta-analysis of CBT for insomnia. JAMA Psychiatry, 81(3), 296-305.
